Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 22Neoplasms 20Lung Neoplasms 10Colorectal Neoplasms 8Uterine Cervical Neoplasms 6Papillomavirus Infections 5Head and Neck Neoplasms 5Fatigue 5Multiple Myeloma 4Lymphoma 4Hematologic Neoplasms 4Urinary Bladder Neoplasms 3Skin Neoplasms 3Prostatic Neoplasms 3Melanoma 3Hematopoietic and Lymphoid System Neoplasm 3Gastrointestinal Neoplasms 3Sleep Wake Disorders 2Skin Cancer Prevention 2Obesity 2Neoplasm Metastasis 2Motor Activity 2Leukemia, Myeloid, Acute 2Leukemia, Lymphocytic, Chronic, B-Cell 2Leukemia 2Hematopoietic and Lymphatic System Neoplasm 2Diabetes Mellitus 2Depression 2Caregiver 2Cancer Survivor 2

Interventions

Cyclophosphamide 67Dexamethasone 52Peripheral Blood Stem Cell Transplantation 37Lenalidomide 37Rituximab 35fludarabine phosphate 34Bortezomib 30Filgrastim 27Etoposide 27Cytarabine 25Carboplatin 25Busulfan 23Radiotherapy 22Melphalan 22Gemcitabine 22Cyclosporine 21pomalidomide 20fludarabine 20Whole-Body Irradiation 20Mycophenolic Acid 20Paclitaxel 19Methotrexate 18venetoclax 17Cisplatin 17pembrolizumab 16Calcium Dobesilate 16Bevacizumab 16Tacrolimus 14Antilymphocyte Serum 14Nivolumab 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Recurrence × Educational Status × Clear all
NCT00226928 2013-12-04

Psychosocial Treatment for Improving Chances of Survival in Women With Breast Cancer

Stanford University

Phase NA Completed
125 enrolled
Breast

Breast Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡